Rubric :   Opinion

JUVENILE DERMATOMYOSITIS. WHAT SHOULD AN ADULT RHEUMATOLOGIST REMEMBER?
Authors: Oshlianska O.A. Shevchenko N.S. Biliavska Iu.V. №86 (4) 2021 / Review: 30
ISCHEMIC AND NON-ISCHEMIC HEART LESIONS IN PATIENTS WITH RHEUMATOID ARTHRITIS. II. INFLUENCE OF TREATMENT ON THE DEVELOPMENT OF HEART DISEASE IN RA
Authors: Uzun K.S. Gnylorybov A.M. Batushkin V.V. Uzun D.Yu. №87 (1) 2022 / Review: 21
ISCHEMIC AND NON-ISCHEMIC HEART LESIONS IN PATIENTS WITH RHEUMATOID ARTHRITIS. I. CLINICAL AND SUBCLINICAL CHANGES IN THE MYOCARDIUM, PREVALENCE AND SEVERE OF ATHEROSCLEROSIS, PECULIARITIES OF INFLUENCE OF TRADITIONAL FACTORS OF RISK, ROLE OF SYSTEMIC INFLAMMATION
Authors: Uzun K.S. Batushkin V.V. Gnylorybov A.M. Uzun D.Yu.... №86 (4) 2021 / Review: 16
Potential options of clinical evaluation in patients with ANCA-associated systemic vasculitis
Author:Kuzmina G.P. №85 (3) 2021 / Review: 13
CRITERIAL AND NON-CRITERIAL ANTIPHOSPHOLIPID SYNDROME: CONCEPTUAL QUESTIONS OF DIAGNOSTICS
Authors: Golovach I.Yu. Chipko T.M. Lazorenko O.O. №85 (3) 2021 / Review: 25
Modern aspects of treatment and monitoring of hand osteoarthritis
Authors: Dubkova A.G. Krylova A.S. Tsymbaliuk T.S. №85 (3) 2021 / Review: 18
JUVENILE SYSTEMIC LUPUS ERYTHEMATOSUS. WHAT SHOULD AN ADULT RHEUMATOLOGIST REMEMBER?
Authors: Biliavska Iu.V. Oshlianska O.A. Shevchenko N.S. №84 (2) 2021 / Review: 19
THE ROLE OF DIET FACTORS IN THE DEVELOPMENT AND MODIFICATION OF THE COURSE OF SYSTEMIC LUPUS ERYTHEMATOSUS
Authors: Yaremenko O.B. Koliadenko D.I. №84 (2) 2021 / Review: 24
DYNAMICS OF DEVELOPMENT OF CHONDROITIN SULFATE AND THE PLACE OF GLYCOSAMINOGLYCAN-PEPTIDE COMPLEXES IN THE TREATMENT OF OSTEOARTHRITIS
Authors: Dubkova A.G. Krylova A.S. Bortkevych O.P. Tsymbaliuk T.S. №83 (1) 2021 / Review: 54
RHEUMATOID ARTHRITIS AND COMORBID PERIODONTITIS: CLINICAL AND PATHOGENETIC FEATURES OF RELATIONS
Authors: Syniachenko O.V. Yermolaieva M.V. Liventsova K.V. Verzilov S.M.... №82 (4) 2020 / Review: 15
SYSTEMIC LUPUS ERYTHEMATOSUS: THE STATE OF THE PROBLEM IN UKRAINE AND THE WORLD
Authors: Protsenko G.O. Dubas V.V. №82 (4) 2020 / Review: 108
TO THE QUESTION OF THE POSSIBILITY AND ACCEPTABILITY OF USING OFF-LABEL DRUGS IN PEDIATRIC RHEUMATOLOGY ACCORDING TO EXPERIENCE WITH RITUXIMAB IN CHILDREN WITH SYSTEMIC CONNECTIVE TISSUE DISEASES THAT ARE RESISTANT TO THERAPY
Authors: Oshlianska O.A. Оmelchenko L.I. №81 (3) 2020 / Review: 20
CARDIOVASCULAR RISK IN PATIENTS WITH OSTEOARTHRITIS: RESULTS OF PAN-UKRAINIAN STUDY PARTNER
Author:Yaremenko O.B. Дата: 2020-06-17 / Review: 136
When does asymptomatic hyperuricemia need treatment?
Дата: 2020-02-03 / Review: 22
Rheumatic immuno-related side effects from cancer immunotherapy
Authors: Golovach I.Yu. Yehudina Ye.D. Ter-Vartanіan S.Kh. №78 (4) 2019 / Review: 40

12345...Последняя »